MIGRAINES & HEADACHES: Highly Recommended
Special Report on a new class 2 medical device that relieves headaches and migraines in 93% of patients trialled.more info...
Nano Superbug Zapper
Revolutionary pocket-size device kills 'super' strains of bacteria and viruses in seconds!more info...
Pain Free Forever - SAVE £5.00
New book reveals 157 natural pain relief breakthroughs your doctor doesn't know aboutmore info...
SAFETOX - THE NATURAL, NON-TOXIC FACELIFT PHENOMENON
Watch wrinkles fade by 83% with this 5 minute-a-day facelift wondermore info...
NEW! . . . SUPER FOODS FOR A SUPER-HEALTHY YOU
Unleash the secret healing power of Nature's ultimate foods - & 'programme' your body to remain free of illnessmore info...
Migraine & Headache
Migraines: Could Painkillers Be Making Your Headaches Worse?
Sometimes a treatment is worse than the disease. But nearly as bad: Sometimes a treatment actually contributes to the health issue it's supposed to address.
This is the case with a common ailment, treated with a common over-the-counter medication, often prompting a return of the ailment, which is treated again, setting up a vicious cycle that many people get caught up in without ever knowing it.
Editor's note: read our Special Report on the side-effects of painkillers and what you can do to eliminate the damage they're causing to you
Epidemic proportions
Writing in a 1990 issue of the journal Headache, Dr John Edmeads, called headaches induced by analgesic medications an 'unrecognised epidemic.'
That assessment of drug rebound headaches is confirmed with a study published in the journal Headache. Researchers at the Samsung Medical Center in Seoul, South Korea, recruited 145 patients with transformed migraine (TM), which is the most common type of chronic daily headache. All of the subjects reported having at least 15 headaches per month for the six months before the trial period began.
To read the rest of the article click here
News Update: There's more news here about a drug-free breakthrough that has been shown to relieve headache and migraine pain in 93% of patients trialled.
Click here to send to a friendShare thisPrinter friendly version
